Get complete Patent Opposition Report for Bayer Healthcare

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Bayer Healthcare's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3230316Jan 5, 2022Treatment Of Age Related Macular Degeneration With A Small Active Choroidal Neovascularization Lesion6
EP1957110Dec 23, 2020Process For Manufacturing Chewable Dosage Forms For Drug Delivery And Products Thereof1
EP2772500Dec 25, 2019Site-Directed Modification Of Fviii1
EP2109394May 23, 2018Analyte-Testing Device2